BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 32633800)

  • 1. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.
    Orkaby AR; Driver JA; Ho YL; Lu B; Costa L; Honerlaw J; Galloway A; Vassy JL; Forman DE; Gaziano JM; Gagnon DR; Wilson PWF; Cho K; Djousse L
    JAMA; 2020 Jul; 324(1):68-78. PubMed ID: 32633800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins, Mortality, and Major Adverse Cardiovascular Events Among US Veterans With Chronic Kidney Disease.
    Barayev O; Hawley CE; Wellman H; Gerlovin H; Hsu W; Paik JM; Mandel EI; Liu CK; Djoussé L; Gaziano JM; Gagnon DR; Orkaby AR
    JAMA Netw Open; 2023 Dec; 6(12):e2346373. PubMed ID: 38055276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
    Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
    JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New statin use, mortality, and first cardiovascular events in older US Veterans by frailty status.
    Orkaby AR; Lu B; Ho YL; Treu T; Galloway A; Wilson PWF; Cho K; Gaziano JM; Alexander KP; Gagnon DR; Djousse L; Forman DE; Driver JA
    J Am Geriatr Soc; 2024 Feb; 72(2):410-422. PubMed ID: 38055194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease.
    Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
    JAMA Cardiol; 2019 Mar; 4(3):206-213. PubMed ID: 30758506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
    Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
    JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System.
    Vassy JL; Lu B; Ho YL; Galloway A; Raghavan S; Honerlaw J; Tarko L; Russo J; Qazi S; Orkaby AR; Tanukonda V; Djousse L; Gaziano JM; Gagnon DR; Cho K; Wilson PWF
    JAMA Netw Open; 2020 Jul; 3(7):e208236. PubMed ID: 32662843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease.
    Lee MT; Mahtta D; Ramsey DJ; Liu J; Misra A; Nasir K; Samad Z; Itchhaporia D; Khan SU; Schofield RS; Ballantyne CM; Petersen LA; Virani SS
    JAMA Cardiol; 2021 Jul; 6(7):782-790. PubMed ID: 33881448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin Discontinuation and Cardiovascular Events Among Older People in Denmark.
    Thompson W; Morin L; Jarbøl DE; Andersen JH; Ernst MT; Nielsen JB; Haastrup P; Schmidt M; Pottegård A
    JAMA Netw Open; 2021 Dec; 4(12):e2136802. PubMed ID: 34854906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study.
    Yang Q; Zhong Y; Gillespie C; Merritt R; Bowman B; George MG; Flanders WD
    BMJ Open; 2017 Jan; 7(1):e011684. PubMed ID: 28119384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020.
    Jacobs JA; Addo DK; Zheutlin AR; Derington CG; Essien UR; Navar AM; Hernandez I; Lloyd-Jones DM; King JB; Rao S; Herrick JS; Bress AP; Pandey A
    JAMA Cardiol; 2023 May; 8(5):443-452. PubMed ID: 36947031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study.
    Shah RV; Spahillari A; Mwasongwe S; Carr JJ; Terry JG; Mentz RJ; Addison D; Hoffmann U; Reis J; Freedman JE; Lima JAC; Correa A; Murthy VL
    JAMA Cardiol; 2017 Jun; 2(6):644-652. PubMed ID: 28315622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Disease Risk Assessment Using Traditional Risk Factors and Polygenic Risk Scores in the Million Veteran Program.
    Vassy JL; Posner DC; Ho YL; Gagnon DR; Galloway A; Tanukonda V; Houghton SC; Madduri RK; McMahon BH; Tsao PS; Damrauer SM; O'Donnell CJ; Assimes TL; Casas JP; Gaziano JM; Pencina MJ; Sun YV; Cho K; Wilson PWF
    JAMA Cardiol; 2023 Jun; 8(6):564-574. PubMed ID: 37133828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.
    Erqou S; Papaila A; Halladay C; Ge A; Liu MA; Jiang L; Lally M; Menon A; Shah NR; Miech E; Virani SS; Zullo AR; Shireman TI; Longenecker CT; Ross D; Sullivan JL; Wu WC; Rudolph JL
    Am Heart J; 2022 Jul; 249():12-22. PubMed ID: 35318028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Use in Older Adults for Primary Cardiovascular Disease Prevention Across a Spectrum of Cardiovascular Risk.
    Sarraju A; Spencer-Bonilla G; Chung S; Gomez S; Li J; Heidenreich P; Palaniappan L; Rodriguez F
    J Gen Intern Med; 2022 Aug; 37(11):2642-2649. PubMed ID: 34505981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
    Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin and clinical outcomes of primary prevention in individuals aged >75 years: The SCOPE-75 study.
    Kim K; Lee CJ; Shim CY; Kim JS; Kim BK; Park S; Chang HJ; Hong GR; Ko YG; Kang SM; Choi D; Ha JW; Hong MK; Jang Y; Lee SH
    Atherosclerosis; 2019 May; 284():31-36. PubMed ID: 30870705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease.
    Mahtta D; Ramsey DJ; Al Rifai M; Nasir K; Samad Z; Aguilar D; Jneid H; Ballantyne CM; Petersen LA; Virani SS
    JAMA Netw Open; 2020 Aug; 3(8):e2011051. PubMed ID: 32816031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease.
    Shavadia JS; Wilson J; Edmonston D; Platt A; Ephraim P; Hall R; Goldstein BA; Boulware LE; Peterson E; Pendergast J; Scialla JJ
    Am Heart J; 2021 Jan; 231():36-44. PubMed ID: 33096103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Perioperative Statin Use With Mortality and Morbidity After Major Noncardiac Surgery.
    London MJ; Schwartz GG; Hur K; Henderson WG
    JAMA Intern Med; 2017 Feb; 177(2):231-242. PubMed ID: 27992624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.